share_log

北陆药业(300016.SZ)通过巴西国家卫生监督局GMP认证

beijing beilu pharmaceutical (300016.SZ) obtained GMP certification from the Brazilian National Health Surveillance Agency.

Zhitong Finance ·  Oct 31 17:38

Beijing Beilu Pharmaceutical (300016.SZ) announced that recently, the company has passed the inspection of the Brazilian National Health Surveillance Agency (ANVISA).

Zhitong Finance APP News, Beijing Beilu Pharmaceutical (300016.SZ) announced that recently, the company has obtained the Good Manufacturing Practice (GMP) certification from the Brazilian National Health Surveillance Agency (ANVISA).

This successful ANVISA GMP certification has created conditions for the company's contrast agents to successfully enter the Brazilian market, playing a very positive role in the company's further expansion into the Brazilian market and other international markets.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment